{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:02:40Z","timestamp":1761292960418},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.radonc.2012.09.004","type":"journal-article","created":{"date-parts":[[2012,10,12]],"date-time":"2012-10-12T17:53:19Z","timestamp":1350064399000},"page":"232-237","source":"Crossref","is-referenced-by-count":13,"title":["Definitive radiotherapy for squamous cell carcinoma of the pyriform sinus"],"prefix":"10.1016","volume":"105","author":[{"given":"Pierre","family":"Blanchard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yungan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ovidiu","family":"Veresezan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Lusinchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Le Ridant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Janot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Daly-Schveitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Bourhis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2012.09.004_b0005","doi-asserted-by":"crossref","unstructured":"Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991;324:1685\u201390.","DOI":"10.1056\/NEJM199106133242402"},{"key":"10.1016\/j.radonc.2012.09.004_b0010","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/88.13.890","article-title":"Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group","volume":"88","author":"Lefebvre","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2012.09.004_b0015","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2012.09.004_b0020","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-0","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2012.09.004_b0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.004_b0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.radonc.2011.05.036","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site","volume":"100","author":"Blanchard","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.004_b0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hed.2890100103","article-title":"Squamous cell carcinoma of the pyriform sinus: retrospective study of 351 cases treated at the Institut Gustave-Roussy","volume":"10","author":"Vandenbrouck","year":"1987","journal-title":"Head Neck Surg"},{"key":"10.1016\/j.radonc.2012.09.004_b0040","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.radonc.2012.09.004_b0045","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/0360-3016(82)90576-4","article-title":"Results of radical radiotherapeutic treatment of carcinoma of the pyriform sinus: experience of the Institut Curie","volume":"8","author":"Bataini","year":"1982","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.004_b0050","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0360-3016(93)90518-Z","article-title":"Radiotherapy alone or combined with neck dissection for T1\u2013T2 carcinoma of the pyriform sinus: an alternative to conservation surgery","volume":"27","author":"Mendenhall","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.004_b0055","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/hed.21011","article-title":"Prognostic impact of tumor volume in patients with stage III\u2013IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy","volume":"31","author":"Chen","year":"2009","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2012.09.004_b0060","article-title":"Definitive radiotherapy for T1\u20132 hypopharyngeal cancer: a single-institution experience","author":"Nakajima","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.004_b0065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijrobp.2008.01.003","article-title":"Definitive radiotherapy for T1\u2013T2 squamous cell carcinoma of pyriform sinus","volume":"72","author":"Rabbani","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.004_b0070","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(09)70266-9","article-title":"Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009","volume":"10","author":"Wee","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2012.09.004_b0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.radonc.2012.03.001","article-title":"Can \u201cearly\u201d and \u201clate\u201d18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?","volume":"103","author":"Castaldi","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.004_b0080","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jnci\/djp007","article-title":"Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation","volume":"101","author":"Pointreau","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2012.09.004_b0085","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2012.09.004_b0090","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2012.09.004_b0095","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0167-8140(11)70005-6","article-title":"Taxane-cisplatin-5FU as induction chemotherapy in locally advanced head and neck squamous cell carcinoma: an individual patient data meta-analysis of the MACH-NC group","volume":"98","author":"Blanchard","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.004_b0100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0360-3016(02)03819-1","article-title":"Late toxicity results of the GORTEC 94\u201301 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT\/SOMA, RTOG\/EORTC, and NCI-CTC scoring systems","volume":"55","author":"Denis","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2012.09.004_b0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2012.09.004_b0110","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.radonc.2012.02.010","article-title":"Heterogeneity in head and neck IMRT target design and clinical practice","volume":"103","author":"Hong","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.004_b0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.radonc.2010.04.012","article-title":"Planning study for available dose of hypoxic tumor volume using fluorine-18-labeled fluoromisonidazole positron emission tomography for treatment of the head and neck cancer","volume":"97","author":"Choi","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.004_b0120","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.radonc.2011.07.025","article-title":"(1)(8)F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer","volume":"101","author":"Delouya","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.09.004_b0125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.radonc.2011.07.029","article-title":"Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance","volume":"101","author":"Hendrickson","year":"2011","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814012003799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814012003799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T06:29:03Z","timestamp":1542695343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814012003799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0167814012003799"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2012.09.004","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}